Elutia (ELUT) Operating Margin (2019 - 2026)
Elutia (ELUT) posted Operating Margin of 203.85% for Q1 2026, down 1.63% sequentially from 200.58% in Q4 2025, and up 2580.0% YoY from 7.61% in Q1 2025.
Elutia (ELUT) Operating Margin (2019 - 2026) Analysis & Trends
Elutia has reported Operating Margin for 8 years, with the latest figure at 203.85% in Q1 2026.
- Quarterly Operating Margin rose 2580.0% year-over-year to 203.85% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 175.27% (up 2779.0% YoY) and the FY2025 annual result came in at 218.91%, down 662.0% from the prior year.
- Operating Margin retreated to 203.85% in Q1 2026 per ELUT's latest filing, from 200.58% in the prior quarter.
- Over five years, Operating Margin peaked at 60.22% in Q1 2022 and troughed at 264.84% in Q4 2024.
- A 5-year average of 155.51% and a median of 144.82% in 2023 frame the typical range for Operating Margin.
- The sharpest annual moves came in 2024 and 2025: Operating Margin tumbled 13024 bps in 2024, then soared 9382 bps in 2025.
- Over 5 years, Operating Margin stood at 144.63% in 2022, then retreated by 0 bps to 144.82% in 2023, then plunged by 83 bps to 264.84% in 2024, then gained by 24 bps to 200.58% in 2025, then decreased by 2 bps to 203.85% in 2026.
- According to Business Quant data, Operating Margin over the past three periods registered 203.85%, 200.58%, and 156.73% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 19.15% |
| 10 | Elutia | 39.87 Mn | 19.98 Mn | 1.45 Mn | -327.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -203.85% |
| Dec 31, 2025 | -200.58% |
| Sep 30, 2025 | -156.73% |
| Jun 30, 2025 | -157.67% |
| Mar 31, 2025 | -229.65% |
| Dec 31, 2024 | -264.84% |
| Sep 30, 2024 | -250.55% |
| Jun 30, 2024 | -135.27% |
| Mar 31, 2024 | -126.67% |
| Dec 31, 2023 | -144.82% |
| Sep 30, 2023 | -120.30% |
| Jun 30, 2023 | -99.34% |
| Mar 31, 2023 | -130.46% |
| Dec 31, 2022 | -144.63% |
| Sep 30, 2022 | -153.31% |
| Jun 30, 2022 | -64.74% |
| Mar 31, 2022 | -60.22% |
| Dec 31, 2021 | -71.47% |
| Sep 30, 2021 | -60.74% |
| Jun 30, 2021 | -37.79% |